GieseJLStanleyTH. Etomidate: A new intravenous anesthetic induction agent. Pharmacotherapy1983; 3: 251–8.
2.
AMA Division of Drugs.AMA drug evaluations. 5th ed.Chicago: American Medical Association, 1983: 409–10.
3.
LedinghamIMWattI. Influence of sedation on mortality in critically ill multiple trauma patients (letter). Lancet1983; 1: 1270.
4.
Etomidate (editorial). Lancet 183;2: 24–5.
5.
FellowsIWByrneAJAllisonSP. Adrenocortical suppression with etomidate (letter). Lancet1983; 2: 54–5.
6.
AllolioBStuttmannRFischerHLeonhardWWinkelmannW. Long-term etomidate and adrenocortical suppression (letter). Lancet1983; 2: 626.
7.
KlausenNOMoelgaardJFergusonAHJensenJKLarsenCPaabyP. Negative synacthen test during etomidate infusion (letter). Lancet1983; 2: 848.
8.
LambertAMitchellRFrostJRatcliffeJGRobertsonWR. Direct in vitro inhibition of adrenal steroidogenesis by etomidate (letter). Lancet1983; 2: 1085.
9.
FragenRJShanksCAMolteniA. Effect on plasma cortisol concentrations of a single induction dose of etomidate or thiopentone (letter). Lancet1983; 2: 625.
10.
SearJWAllenMCGalesMSuppression by etomidate of normal cortisol response to anaesthesia and surgery (letter). Lancet1983; 2: 1028.
11.
FellowsIWBastowMDByrneAJAllisonSP. Adrenocortical suppression in multiply injured patients: A complication of etomidate treatment. Br Med J1983; 287: 1835–7.
